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For intracellular parasites that strongly prefer infecting a particular cell type, systemic spread is
challenging. Masaki et al. show that the leprosy bacterium cleverly expands its repertoire by driving
dedifferentiation of Schwann cells, their preferred host, to cells with stem cell properties that can
subsequently redifferentiate into mesodermal lineages.Leprosy is an age-old scourge for human
civilization that despite recent successes
in therapy and prevention still represents
a significant global health problem (Scol-
lard et al., 2006). Its causative agent is
Mycobacterium leprae, an obligate intra-
cellular bacterial pathogen. Although
M. leprae became the first bacterium
identified as a cause of human disease,
it has kept its secrets well. M. leprae
exhibits a strong tropism for Schwann
cells (Stoner, 1979), the glial population
that ensheath axons of the peripheral
nervous system (Jessen and Mirsky,
2005) (Figure 1). The pathogen’s predilec-
tion for these cells is the primary cause for
sensory loss and sensorimotor dysfunc-
tion in leprosy patients (Stoner, 1979). In
recent years, clues have been obtained
that indicate how M. leprae recognizes
and enters Schwann cells and how it
modifies the properties of its host cells
to its own advantage. An unresolved
issue is how M. leprae spreads from
Schwann cells to other cell types,
including skeletal and smooth muscle
cells during late stages of this chronic
disease. In this issue of Cell, Masaki
et al. (2013) identify an unexpected mech-
anism by which the pathogen triggers its
dissemination. Intriguingly, this involves
dedifferentiation and reprogramming of
its host Schwann cell to a stem-cell-like
state.
Previous studies have shown that
interactions between several bacterial
adhesins and a2 laminin in the Schwann
cell basal lamina mediate bacterial
attachment and that a-dystroglycan and
ErbB2 serve as receptors on theSchwann cell surface (for review see
Pinheiro et al., 2011; Rambukkana,
2010). These primary contacts not only
mediate entry of M. leprae into its host
cell but also induce dedifferentiation by
activating Erk1/2 signaling. The resulting
immature Schwann cells provide a
much better environment for the bacte-
rium than differentiated cells, especially
those that are myelinating. Their ability
to proliferate furthermore increases the
pool of cells in which the bacteria can
replicate (Figure 1).
Masaki et al. (2013) now show that if
confronted with high bacterial load for
extended periods, infected Schwann cells
dedifferentiate even further, losing their
lineage characteristics and adopting an
expression profile indicative of a mesen-
chymal stem cell. As an early event in
this reprogramming process, the tran-
scription factor Sox10 is exported from
the nucleus to the cytoplasm, followed
by downregulation of its expression and
methylation of its gene. Considering that
Sox10 is not only a critical factor of myeli-
nation but also an essential determinant
of Schwann cell identity (Finzsch et al.,
2010), it is very likely that Sox10 inactiva-
tion and elimination is a key event in
extinction of lineage properties and
a central step in the bacterial reprogram-
ming strategy.
When further kept in mesenchymal
stem cell medium the bacteria-laden
stem-cell-like cells develop a series of
remarkable properties (Figure 1). They
are not only strongly proliferative but
also highly migratory, which may be an
important factor in pathogen dissemina-Cell 15tion. These cells are also capable of redif-
ferentiating into various mesodermal
cell types and of integrating into skeletal
and smooth muscles, thereby spreading
M. leprae directly to these tissues. Finally,
Masaki et al. find that these infected cells
with stemcell properties secrete acocktail
of immunomodulatory molecules that
attract macrophages to which M. leprae
is transferred. This results in granuloma
formation, and the infected macrophages
serve as another vehicle for systemic
pathogen dissemination.
Two aspects make this study particu-
larly exciting: first, it shows that a path-
ogen is capable of exploiting the genomic
plasticity of a highly specialized differ-
entiated cell by erasing its identity and
reprogramming it. Second, it provides
plausible mechanisms for pathogen
dissemination during the course of
leprosy.
As with every study, there are limitations
and caveats. Most results are obtained in
cell culture and in vivo validation is
confined to a nude mouse model in which
Schwann-cell-derived cells with stem-
cell-like properties were transplanted into
skeletal muscle after cardiotoxin-induced
injury. This limitation is inevitable as no
animal model exists that recapitulates the
essential features of the human disease
(Pinheiro et al., 2011; Rambukkana,
2010). As a consequence, it is currently
very difficult, if not impossible to show
Schwann cell reprogramming in vivo,
let alone in the patient. Additionally, it is
unclear whether a reprogrammed cell
in vivo completely resembles and behaves
as its counterpart in vitro. To a large extent,2, January 17, 2013 ª2013 Elsevier Inc. 15
Figure 1. Infected Schwann Cells Acquire Stem-Cell-like Properties
M. leprae infects mature nonmyelinating and myelinating Schwann cells in
contact with axons and causes their dedifferentiation to immature Schwann
cells. According to Masaki et al. (2013) the transcription factor Sox10 is
expelled from the nucleus and degraded as the bacterial load increases.
Following identity loss, former Schwann cells are reprogrammed to stem-cell-
like cells with the ability to redifferentiate into infected mesodermal cells and
attract macrophages, resulting in extensive bacterial dissemination. The
curved blue arrows indicate the capacity for cell proliferation.this depends on the signals it
receives from its environment,
and these may vary from
in vitro culture. As a result,
reprogrammed cells in vivo
may well implement alterna-
tive or additional develop-
mental choices depending
on the properties of their
niche. Theblood-nervebarrier
adds another layer of
complexity in vivo because
its presence influencesmigra-
tion of infected Schwann-cell-
derived stem-cell-like cells
and macrophages.
Beyond its immediate rele-
vance for the pathophysi-
ology of leprosy, the current
study establishes an experi-
mental system that may yield
valuable insights into both
Schwann cell and stem cell
biology. To exploit this poten-
tial, researchers need to
better define the underlying
molecular mechanisms. Con-
sidering the known role of
Sox10 in Schwann cell iden-
tity and the relevance of
identity loss for reprogram-
ming, it will be important to
figure out how M. leprae
interferes with Sox10. Does
the bacterium directly target
this host cell transcription
factor? Does it actively cause
Sox10 export from the
nucleus, degradation and
gene silencing? And if so, by
what mechanisms? It will
also be interesting to learn
whether loss of Sox10 is
the single most important
factor for reprogramming or
whether this event sets the
stage for the action of otherfactors after Schwann cell identity loss.
The ability of Sox10 to interact physically
and functionally with transcription factors,16 Cell 152, January 17, 2013 ª2013 Elsevierchromatin remodelers, and histone modi-
fiers is certainly compatible with a prom-
inent role (Jacob et al., 2011; WeiderInc.et al., 2012; Wißmu¨ller et al.,
2006). The future will tell.ACKNOWLEDGMENTS
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